NOVARTIS N (NOVN) — research page
CH · ch-cm-kg/SIX/NOVN · as of 2026-11-06
Identity and listing
The issuer is NOVARTIS N, listed on SIX under ticker NOVN, ISIN CH0012005267, LEI 5493007HIVTX6SY6XD66. Its security type is Corporate and its jurisdiction is Switzerland (Zefix-registered corporation). Segment is not on the record, and sector is not on the record because the SIX feed returns an empty ICB industry for this line. Status is listed, not halted.
| field | value | source · read date |
|---|---|---|
| name | NOVARTIS N | source · 2026-11-06 |
| exchange | SIX | source · 2026-11-06 |
| ticker | NOVN | source · 2026-11-06 |
| ISIN | CH0012005267 | source · 2026-11-06 |
| LEI | 5493007HIVTX6SY6XD66 | source · 2026-11-09 |
| security type | Corporate | source · 2026-11-06 |
| segment | not on the record | |
| sector | not on the record | |
| jurisdiction | Switzerland (Zefix-registered corporation) | source · 2026-11-06 |
| status | listed, not halted | source · 2026-11-09 |
The disclosure read
The record holds 34 filings in the twelve months from 2025-11-06 to 2026-11-06, across 25 filing days: 18 newswire releases and 16 register mutations. The median gap between filing days is 6.5 days. The latest filing is a newswire release dated 2026-10-27, which is 10 days before the record date of 2026-11-06. On SIX the median cadence gap is 29.5 days across 607 issuers, the median filings count is 0, and the median latency is 14 days. Sector peer figures are not on the record for CH.
| filings | median gap between filing days | days from latest filing to as-of | |
|---|---|---|---|
| this issuer | 34 | 6.5 | 10 |
| exchange median: SIX (607 issuers) | 0 | 29.5 | 14 |
| date | type | category | filing |
|---|---|---|---|
| 2026-10-27 | newswire_release | Novartis delivered sales growth and core margin expansion | |
| 2026-10-23 | register_mutation | HR02 | HR02 Change Kaderkasse Novartis, Basel, new Pensionskasse Novartis 3 |
| 2026-10-23 | newswire_release | Novartis remibrutinib delivered comprehensive disease | |
| 2026-10-22 | register_mutation | HR02 | HR02 Change Novartis Pharma Schweiz AG, Risch |
| 2026-10-21 | newswire_release | Novartis receives European Commission approval for |
window 2025-11-06 to 2026-11-06 · the node's disclosure lines, as get_filings serves them
Auditor
The auditor of record is KPMG, with its location not on the record. Auditor changes are not on the record, because this register has no lifecycle type map yet.
Events and halts
Listing, delisting, name change, domicile change and segment move are not on the record, because this register has no lifecycle type map yet. The issuer is listed and not halted.
Orderability
The outcome is ACM-200 for Privatkundinnen und -kunden, professionelle Kunden and institutionelle Kunden, and it is determinable in each case. The rule version is acm-68000/ch/finsa-product-duties/r1, and the chapter is as of 2026-11-04.
| client category | outcome |
|---|---|
| Privatkundinnen und -kunden | ACM-200 |
| institutionelle Kunden | ACM-200 |
| professionelle Kunden | ACM-200 |
rule acm-68000/ch/finsa-product-duties/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability
Coverage
No research houses were found on the issuer's investor-relations pages read; the count is 0.
Open research
No openly published research notes were found; the count is 0.
Licensed
Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.
| licensor | entitlement | title | date | source |
|---|---|---|---|---|
| none loaded |
As-of depth
The vintage is not sealed. No issuer years are sealed, the market's earliest sealed date is not on the record, and the live record began is not on the record.
Sources
8 source pages are named on this page; every value above carries its own source page and read date in the numbers.
- 10.1
- https://www.six-group.com/en/products-services/the-swiss-stock-exchange/market-data/shares/share-explorer.html (identity.exchange)
- 10.2
- https://www.zefix.ch/en/search/entity/list?name=NOVARTIS%20%7C%20NOVARTIS%20AG (identity.jurisdiction)
- 10.3
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- 10.4
- https://mcp.ch-cm-kg.ai/events/SIX/NOVN (the disclosure lines)
- 10.5
- https://www.ser-ag.com/sheldon/official_notices/v2/find.json ; https://www.bxswiss.com/suspensions (the halt flag)
- 10.6
- https://www.novartis.com/sites/novartis_com/files/novartis-annual-report-2025.pdf (the auditor)
- 10.7
- https://mcp.ch-cm-kg.ai/book/aio.json (the orderability chapter)
- 10.8
- https://mcp.ch-cm-kg.ai/record/SIX/NOVN (the record)
Read it by agent
The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"CH0012005267"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:35846e6d903bdb58.